Related Experiment Videos
Rheumatoid arthritis II: systemic manifestations
Maryland State Medical Journal
|May 1, 1982
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension.
The European respiratory journal·2009
Fatigue: an overlooked determinant of physical function in scleroderma.
Rheumatology (Oxford, England)·2008
Management of Severe Raynaud's Phenomenon.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
High-dose cyclophosphamide without stem cell rescue in scleroderma.
Annals of the rheumatic diseases·2007
Abnormal exhaled ethane concentrations in scleroderma.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals·2006
Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.
Case reports in dermatological medicine·2026
Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.
Frontiers in endocrinology·2026
Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.
Kidney diseases (Basel, Switzerland)·2026
Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.
Frontiers in cell and developmental biology·2026